Research.Patient.info
Exocrine Pancreatic Insufficiency (EPI) research hub
2 indexed studies · 2 currently recruiting
- not yet recruitingPHASE2
A Study to Evaluate Safety and Explore Efficacy of New Lipase NHS7108 in Adult Participants With Exocrine Pancreatic Insufficiency.
This study is testing a new capsule, NHS7108, for people with Exocrine Pancreatic Insufficiency (EPI). It compares the new medicine to a standard treatment (Zenpep®) to see how safe it is and how well it helps the body digest food.
United States · Bulgaria · Hungary - recruiting
OSPREY is a Post-market, Global, Multicentre, Observational, Prospective Registry.
The OSPREY Registry is looking at how a device called OncoSil™ works in people with locally advanced pancreatic cancer in normal hospital care. It watches how well the device performs and if there are any side effects when used with standard chemotherapy.
Spain · United Kingdom